Norway said on Friday (March 26) that the authorities will extend the moratorium on the use of the AstraZeneca vaccine until April 15.
Agence France-Presse reported that Norwegian officials said that the authorities need more time to investigate the possible link between the vaccine and blood clots. In a statement, Geir Bukholm, director of the Infection Control Division of the Norwegian Institute of Public Health, said that extending the moratorium on the AstraZeneca vaccine was a difficult but correct decision, and the authorities believed that more investigations were necessary.
The European Medicines Regulatory Agency (EMA) said last week that the AstraZeneca vaccine was “safe and effective” and said that the vaccine was not associated with a higher risk of developing blood clots. However, EMA said it cannot “absolutely rule out” the link between the AstraZeneca vaccine and rare blood coagulation diseases.